<![CDATA[
<p style="text-align: center;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><u><b>유투바이오 공모주청약 소개</b></u></span></p><div class="figure-img" data-ke-type="image" data-ke-style="alignCenter" data-ke-mobilestyle="widthOrigin"><img src="https://t1.daumcdn.net/cafeattach/11Cw7/681728ae37226aef550d0b14e96092322f8916cb" class="txc-image" data-img-src="https://t1.daumcdn.net/cafeattach/11Cw7/681728ae37226aef550d0b14e96092322f8916cb" data-origin-width="459" data-origin-height="489"></div><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">종목명</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">유투바이오</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">사업개요</span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">체외진단검사 서비스와 의료IT서비스를 주요 사업으로 영위</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">공모일정 (환불일)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">2023.10.23 ~ 24 (2023.10.26) </span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">공모주식수 (일반)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,128,720 (282,180)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">신주 (구주)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,128,720 (0)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">상장예정주식 (%)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">11,287,196 (100.00)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">시가 총액</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">496억6천만 원</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">우리사주 (%)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">0 (0.00)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">공모희망가 </span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">3,300 ~ 3,900</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">확정공모가 (코넥스 10월20일 종가)</span></td><td colspan="1" rowspan="1"><span style="color: #ff0010;" data-ke-size="size18"><b>4,400 (6,990)</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">기관수요경쟁률</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">1,792건 (1,276.73)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">의무보유확약기관(%)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">42건 (2.35)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">유통가능구주주식 (%)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">2,387,496 (21.15)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">유통가능주식 (%)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">3,516,216 (31.15)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">청약한도 우대 (온라인) </span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">27,000 (18,000) </span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">주간사</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">신한투자증권</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">상장 예정일</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">2023.11.02</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #009e25;" data-ke-size="size18"><b>최종 경쟁율 </b></span></td><td colspan="1" rowspan="1"><span style="color: #009e25;" data-ke-size="size18"><b>0.00</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #009e25;" data-ke-size="size18"><b>청약 금액</b></span></td><td colspan="1" rowspan="1"><span style="color: #009e25;" data-ke-size="size18"><b>0억0백만원 </b></span></td></tr></tbody></table></div><p> </p><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">[2023년 반기 기준 유사회사 평균 PER]</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(단위 : 원, 주, 배)</span></td></tr></tbody></table></div><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>구 분</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>(주)녹십자엠에스</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>(주)비트컴퓨터</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">2023년 반기 기준 당기순이익(단위 : 원)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,703,022,440</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">3,295,398,940</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">발행주식총수</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">21,117,283</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">16,623,293</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">적용 주당순이익(EPS)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">161.3</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">396.5</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">기준주가</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">4,259</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">5,786</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">PER(배, 기준주가/적용 주당순이익)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">26.41</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">14.59</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">평균 PER(배)</span></td><td colspan="2" rowspan="1"><span style="color: #000000;" data-ke-size="size18">20.50</span></td></tr></tbody></table></div><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">[PER에 의한 ㈜유투바이오의 평가가치]</span></td></tr></tbody></table></div><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>구 분</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>산출 내역</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>비 고</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">2023년 반기 기준 당기순이익(A)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,236,030천원</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">​</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(연환산) 당기순이익(B)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">2,472,060천원</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">​</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">적용 PER(C)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">20.50배</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">-</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">기업가치 평가액(D)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">50,677,219천원</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">D=(BXC)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">적용주식수(E)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">11,287,196주</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">​</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">주당 평가가액(F)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">4,490원</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">F=(D/E) </span></td></tr></tbody></table></div><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">자료: 전자공시시스템(Dart)</span></p><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">종목명(EPS)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">23년 반기기준 </span><br><span style="color: #000000;" data-ke-size="size18">실적 적용 기준주가(PER)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">10.20 종가(PER)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">녹십자엠에스(161.3)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">4,259(26.41)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">3,595(22.29)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">비트컴퓨터(396.5)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">5,786(14.59)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">5,110(12.89)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">적용 평균 PER</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(20.50)</span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">(17.59)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">주당 EPS</span></td><td colspan="2" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">219</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">주당평가액</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">4,490원 </span></td><td colspan="1" rowspan="1"><span style="color: #8a837e;" data-ke-size="size18">3,852원</span></td></tr></tbody></table></div><p> </p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>(유투바이오)</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>유투바이오 확정공모가 4,400원은 </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>할인율은 2.00%</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>per은 20.09</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>온라인 일반 청약수수료 : 2,000원</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>최소청약수량 : 50주 (110,000원)</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>유투바이오의 장점 </b></span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>1) </b></span><span style="color: #ff0010; background-color: #ffffff;" data-ke-size="size18">개발과 성능 평가, 허가를 모두 유기적으로 진행</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">할 수 있는 연구소의 업무 프로세스와 연구원의 역량 또한 동사 체외진단 의료기기 개발의 강점입니다.</span></p><p><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">동사에서는 인체 유전질환, 감염성 질환의 분자진단을 위한 다양한 체외진단 의료기기의 개발을 위하여 새로운 기술의 도입과 연구를 지속하고 있습니다.</span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18">2) </span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">코로나 검사 외에도 </span><span style="color: #ff0010; background-color: #ffffff;" data-ke-size="size18">다양한 종류의 일반진단검사 및 분자진단검사 용역 서비스를 제공</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">하고, 장원의료재단을 핵심 고객으로 두고 있어 </span><span style="color: #ff0010; background-color: #ffffff;" data-ke-size="size18">사업의 안정성은 양호</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">한 것으로 판단</span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">3) </span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">2023년 반기 기준 리스부채를 제외하면 당사는 </span><span style="color: #ff0010; background-color: #ffffff;" data-ke-size="size18">무차입 상태</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">이며, 당사는 이자비용을 충당하기 위한 충분한 규모의 영업이익을 창출하고 있어 </span><span style="color: #ff0010; background-color: #ffffff;" data-ke-size="size18">당사 재무안정성은 우수</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">한 것으로 판단</span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>유투바이오의 단점</b></span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>1)</b></span><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"> </span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">영업이익(률)은 2022년까지 지속적으로 증가했으나, COVID-19 관련 매출 감소의 영향으로 </span><span style="color: #0078cb; background-color: #ffffff;" data-ke-size="size18">2023년 상반기 영업이익은 전년동기대비 -96.58% 감소</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">했으며, </span><span style="color: #0078cb; background-color: #ffffff;" data-ke-size="size18">영업이익률은 3.29%수준으로 하락</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">했습니다</span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>2) 비교기업 주가 하락세</b></span></p><p style="text-align: left;"><span style="color: #8a837e; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>기타사항</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>1. </b></span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>최근 </b></span><span style="color: #141414; background-color: #ffffff;" data-ke-size="size18"><b>3개년</b></span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b> 및 2023년 반기 실적 추이 (단위: 천원, %)</b></span></p><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>구분</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>2020년도</b></span><br><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>제12기</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>2021년도</b></span><br><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>제13기</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>2022년도</b></span><br><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>제14기</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>2023년도 반기</b></span><br><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size18"><b>제15기 반기</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">매출액</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">23,982,617</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">50,552,624</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">69,013,134</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">16,887,814</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">영업이익</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">949,276</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">9,027,233</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">15,707,796</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">555,563</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">당기순이익</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(1,480,589)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">9,236,341</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">13,159,995</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,236,030</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">경상연구개발비</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,231,748</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">1,775,412</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">2,129,180</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">995,166</span></td></tr></tbody></table></div><p><span style="color: #000000;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>2. </b></span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>최근 </b></span><span style="color: #141414; background-color: #ffffff;" data-ke-size="size18"><b>3개년</b></span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b> 및 2023년 1분기 주요 재무 안정성 지표 현황 (단위: %) </b></span></p><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size16"><b>재무비율</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size16"><b>2023년 2분기</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size16"><b>2022년</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size16"><b>2021년</b></span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #dcdcdc;" data-ke-size="size16"><b>2020년</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">유동비율</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">527%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">327%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">219%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">149%</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">부채비율</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">31.0%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">50.8%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">92.0%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">287.0%</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">순차입금의존도</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">-69.2%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">-71.8%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">-35.1%</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">16.8%</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">이자보상배율(배)</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">30.93</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">182.12</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">15.55</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size16">1.10</span></td></tr></tbody></table></div><p><span style="color: #000000;" data-ke-size="size16">​</span></p><p style="text-align: justify;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18">3.</span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b> </b></span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>자금의 세부 사용계획​ (단위 : 원)</b></span></p><div class="table-wrap"><table data-ke-type="table" data-ke-align="alignLeft" style="width: 100%;" border="1"><tbody><tr><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #d7d7d7;" data-ke-size="size18">구분</span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #d7d7d7;" data-ke-size="size18">세부 내역</span></td><td colspan="1" rowspan="1"><span style="color: #000000; background-color: #d7d7d7;" data-ke-size="size18">금액(원)</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">운영자금</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(1) 의료정보솔루션 사업 강화</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18"> 500,000,000</span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">기타</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(2) 신수종사업 발굴</span></td><td colspan="1" rowspan="1"><span style="color: #ff0000;" data-ke-size="size18"><b>811,842,030</b></span></td></tr><tr><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">타법인증권취득자금</span></td><td colspan="1" rowspan="1"><span style="color: #000000;" data-ke-size="size18">(3) 의료정보시스템 관련 기업 인수합병</span></td><td colspan="1" rowspan="1"><span style="color: #ff0000;" data-ke-size="size18"><b>3,500,000,000</b></span></td></tr></tbody></table></div><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>출처: dart 투자설명서</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>공모가는 희망공모가 상단초과로, </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>기관수요예측 결과가 양호 합니다.</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>고로 개인경쟁률은 높을 것으로 </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>예상되는군요. </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>저는 공모주청약시 경쟁률 및 분위기 확인하면서 </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>청약여부를 판단할 예정이나, </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>현재로는</b></span><span style="color: #ff0010; background-color: #ffffff;" data-ke-size="size18"><b> 적정량 비례 참여</b></span><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>할 것 같습니다.</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>최근 비교기업주가가 하락하여 </b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>아주 긍정적으로 보이진 않습니다.</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>고로 이웃님들은 마지막까지 잘 판단하시어</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>공모주청약하시길 바랍니다.</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>​</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>디앤...</b></span></p><p style="text-align: left;"><span style="color: #000000; background-color: #ffffff;" data-ke-size="size18"><b>[IPO 공모주청약에 대한 단순 검토내용이며, 권유하는 것은 아닙니다]</b></span></p><p><b> <a href="https://blog.naver.com/soonupp/223242482909" target="_top" class="ke-link">유투바이오 공모주청약 : 네이버 블로그 (naver.com)</a> </b></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="유투바이오 공모주청약" data-og-description="유투바이오 공모주청약 소개 자료: 전자공시시스템(Dart) (유투바이오) 유투바이오 확정공모가 4,400원은 ..." data-og-host="blog.naver.com" data-og-source-url="https://blog.naver.com/soonupp/223242482909" data-og-url="https://blog.naver.com/soonupp/223242482909" data-og-image="https://scrap.kakaocdn.net/dn/y6s3j/hyUgM0v5Sj/UeQQ4pQQqhmPawpQeSyOYk/img.png?width=459&height=489&face=0_0_459_489"><a href="https://blog.naver.com/soonupp/223242482909" target="_blank" data-source-url="https://blog.naver.com/soonupp/223242482909"><div class="og-image"><img src="https://scrap.kakaocdn.net/dn/y6s3j/hyUgM0v5Sj/UeQQ4pQQqhmPawpQeSyOYk/img.png?width=459&height=489&face=0_0_459_489" alt="" xxonerror="this.src="//img1.kakaocdn.net/thumb/C200x200/?fname=https%3A%2F%2Ft1.daumcdn.net%2Fcafe_image%2Fcafe_meta_image_190529.png""></div><div class="og-text"><p class="og-title">유투바이오 공모주청약</p><p class="og-desc">유투바이오 공모주청약 소개 자료: 전자공시시스템(Dart) (유투바이오) 유투바이오 확정공모가 4,400원은 ...</p><p class="og-host">blog.naver.com</p></div></a></div><p> </p>
<!-- -->]]>
카페 게시글
검색이 허용된 게시물입니다.
공모이야기
공모주
2023년10월23~24(화)(넥)유투바이오 221800 공모주 청
하얀 토끼
추천 7
조회 2,754
23.10.21 09:18
댓글 17
다음검색
첫댓글 네이버 블로거 전광석화님의 포스팅입니다. 감사합니다
감사합니다.
풀비례 금액이 꽤 작을 때
경쟁률이 어찌될지 궁금하네요.
감사합니다.
고맙습니다
감사합니다~~
하얀토끼님 전광석화님 모두 감사합니다
감사합니다
감사합니다.
감사합니다~~
감사합니다.
감사합니다.
감사합니다
감사합니다
현재 당사경쟁률 467 : 1 입니다.
최종
비례경쟁률 2,573.70:1
청약건수 82,886건 균등 1.70주
아이고
일부러 0.6주에 맞춘다고
3시50분에
800주 신청했는데
경쟁률에 두배를 해야한다는 걸 깜박 잊었네요ㅠ